Skip to main content
Erschienen in: Clinical Neuroradiology 1/2023

07.07.2022 | Original Article

Long-Term Middle Meningeal Artery Caliber Reduction Following Trisacryl Gelatine Microsphere Embolization for the Treatment of Chronic Subdural Hematoma

verfasst von: Eimad Shotar, Eric Barberis, Lydia Chougar, Sacha Bensoussan, Damien Parat, Haroun Ghannouchi, Kevin Premat, Stephanie Lenck, Vincent Degos, Stéphane Lehericy, Nader-Antoine Sourour, Bertrand Mathon, Frédéric Clarençon

Erschienen in: Clinical Neuroradiology | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Middle meningeal artery (MMA) particle embolization is a promising treatment of chronic subdural hematomas (CSDH). The main purpose of this study is to measure MMA proximal caliber and assess the visibility of the two main MMA branches as a surrogate for long-term distal arterial patency following MMA CSDH embolization with trisacryl gelatine microspheres (TAGM).

Methods

This is a single-center retrospective study. All patients having undergone MMA TAGM only embolization for CSDH treatment between 15 March 2018 and 6 June 2020 with an interpretable follow-up magnetic resonance imaging (MRI) examination and no confounding factors were included. Patients were compared with controls matched for age, sex and MRI machine. Two independent readers analyzed the MRI images.

Results

In this study, 30 patients having undergone embolization procedures using TAGM of 36 MMAs were included. The follow-up MRI scans were performed after a mean delay of 14.8 ± 7.1 months (range 4.9–29.4 months). The mean diameter of TAGM embolized MMAs (1 mm; 95% confidence interval, CI 0.9–1.1) was significantly smaller than the mean diameter of paired control MMAs (1.3 mm; 95% CI 1.3–1.4) (p < 0.001). The mean proximal diameter of the embolized MMAs (0.9 mm; 95% CI 0.7–1.1) was significantly smaller than the mean diameter of the contralateral MMAs in the same patients (1.4 mm; 95% CI 1.3–1.6)(p < 0.001).

Conclusion

Long-term follow-up MRI demonstrated a significant impact of TAGM embolization on MMA proximal caliber as well as on the visibility of the two main MMA branches. All comparisons indicated that there was a probable lasting impact of embolization on the patency of distal branches.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
4.
Zurück zum Zitat Shotar E, Meyblum L, Premat K, Lenck S, Degos V, Grand T, Cortese J, Pouvelle A, Pouliquen G, Mouyal S, Boch AL, Carpentier A, Sourour NA, Mathon B, Clarençon F. Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma. J Neurointerv Surg. 2020;12:1209-13. https://doi.org/10.1136/neurintsurg-2020-016048.CrossRefPubMed Shotar E, Meyblum L, Premat K, Lenck S, Degos V, Grand T, Cortese J, Pouvelle A, Pouliquen G, Mouyal S, Boch AL, Carpentier A, Sourour NA, Mathon B, Clarençon F. Middle meningeal artery embolization reduces the post-operative recurrence rate of at-risk chronic subdural hematoma. J Neurointerv Surg. 2020;12:1209-13. https://​doi.​org/​10.​1136/​neurintsurg-2020-016048.CrossRefPubMed
5.
Zurück zum Zitat Kang J, Whang K, Hong SK, Pyen JS, Cho SM, Kim JY, Kim SH, Oh JW. Middle Meningeal Artery Embolization in Recurrent Chronic Subdural Hematoma Combined with Arachnoid Cyst. Korean J Neurotrauma. 2015;11:187-90.CrossRefPubMedPubMedCentral Kang J, Whang K, Hong SK, Pyen JS, Cho SM, Kim JY, Kim SH, Oh JW. Middle Meningeal Artery Embolization in Recurrent Chronic Subdural Hematoma Combined with Arachnoid Cyst. Korean J Neurotrauma. 2015;11:187-90.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Matsumoto H, Hanayama H, Okada T, Sakurai Y, Minami H, Masuda A, Tominaga S, Miyaji K, Yamaura I, Yoshida Y. Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review. J Clin Neurosci. 2018;49:40-7.CrossRefPubMed Matsumoto H, Hanayama H, Okada T, Sakurai Y, Minami H, Masuda A, Tominaga S, Miyaji K, Yamaura I, Yoshida Y. Which surgical procedure is effective for refractory chronic subdural hematoma? Analysis of our surgical procedures and literature review. J Clin Neurosci. 2018;49:40-7.CrossRefPubMed
8.
Zurück zum Zitat Fiorella D, Arthur AS. Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg. 2019;11:912-5.CrossRefPubMed Fiorella D, Arthur AS. Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg. 2019;11:912-5.CrossRefPubMed
9.
Zurück zum Zitat Shotar E, Premat K, Barberis E, Talbi A, Lenck S, Cohen C, Degos V, Sourour NA, Mathon B, Clarençon F. Dural arteriovenous fistula formation following bilateral middle meningeal artery embolization for the treatment of a chronic subdural hematoma: a case report. Acta Neurochir (Wien). 2021;163:1069-73. https://doi.org/10.1007/s00701-020-04696-w.CrossRefPubMed Shotar E, Premat K, Barberis E, Talbi A, Lenck S, Cohen C, Degos V, Sourour NA, Mathon B, Clarençon F. Dural arteriovenous fistula formation following bilateral middle meningeal artery embolization for the treatment of a chronic subdural hematoma: a case report. Acta Neurochir (Wien). 2021;163:1069-73. https://​doi.​org/​10.​1007/​s00701-020-04696-w.CrossRefPubMed
10.
Zurück zum Zitat Pouvelle A, Pouliquen G, Premat K, Chougar L, Lenck S, Degos V, Sourour NA, Mathon B, Clarençon F, Shotar E. Larger Middle Meningeal Arteries on Computed Tomography Angiography in Patients with Chronic Subdural Hematomas as Compared with Matched Controls. J Neurotrauma. 2020;37:2703-8. https://doi.org/10.1089/neu.2020.7168.CrossRefPubMed Pouvelle A, Pouliquen G, Premat K, Chougar L, Lenck S, Degos V, Sourour NA, Mathon B, Clarençon F, Shotar E. Larger Middle Meningeal Arteries on Computed Tomography Angiography in Patients with Chronic Subdural Hematomas as Compared with Matched Controls. J Neurotrauma. 2020;37:2703-8. https://​doi.​org/​10.​1089/​neu.​2020.​7168.CrossRefPubMed
11.
Zurück zum Zitat Wang CY, Hu J, Sheth RA, Oklu R. Emerging Embolic Agents in Endovascular Embolization: An Overview. Prog Biomed Eng (Bristol). 2020;2:012003.CrossRefPubMed Wang CY, Hu J, Sheth RA, Oklu R. Emerging Embolic Agents in Endovascular Embolization: An Overview. Prog Biomed Eng (Bristol). 2020;2:012003.CrossRefPubMed
12.
Zurück zum Zitat Carli DF, Sluzewski M, Beute GN, van Rooij WJ. Complications of particle embolization of meningiomas: frequency, risk factors, and outcome. AJNR Am J Neuroradiol. 2010;31:152-4.CrossRefPubMedPubMedCentral Carli DF, Sluzewski M, Beute GN, van Rooij WJ. Complications of particle embolization of meningiomas: frequency, risk factors, and outcome. AJNR Am J Neuroradiol. 2010;31:152-4.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Duvnjak S, Ravn P, Green A, Andersen PE. Clinical long-term outcome and reinterventional rate after uterine fibroid embolization with nonspherical versus spherical polyvinyl alcohol particles. Cardiovasc Intervent Radiol. 2016;39:204-9.CrossRefPubMed Duvnjak S, Ravn P, Green A, Andersen PE. Clinical long-term outcome and reinterventional rate after uterine fibroid embolization with nonspherical versus spherical polyvinyl alcohol particles. Cardiovasc Intervent Radiol. 2016;39:204-9.CrossRefPubMed
14.
Zurück zum Zitat Lewis AL, Adams C, Busby W, Jones SA, Wolfenden LC, Leppard SW, Palmer RR, Small S. Comparative in vitro evaluation of microspherical embolisation agents. J Mater Sci Mater Med. 2006;17:1193-204. CrossRefPubMed Lewis AL, Adams C, Busby W, Jones SA, Wolfenden LC, Leppard SW, Palmer RR, Small S. Comparative in vitro evaluation of microspherical embolisation agents. J Mater Sci Mater Med. 2006;17:1193-204. CrossRefPubMed
15.
Zurück zum Zitat Sun X, Dai H, Guo P, Sha X. Biocompatibility of a new kind of polyvinyl alcohol embolic microspheres: in vitro and in vivo evaluation. Mol Biotechnol. 2019;61:610-21.CrossRefPubMed Sun X, Dai H, Guo P, Sha X. Biocompatibility of a new kind of polyvinyl alcohol embolic microspheres: in vitro and in vivo evaluation. Mol Biotechnol. 2019;61:610-21.CrossRefPubMed
16.
Zurück zum Zitat Hu J, Albadawi H, Chong BW, Deipolyi AR, Sheth RA, Khademhosseini A, Oklu R. Advances in biomaterials and technologies for vascular embolization. Adv Mater. 2019;31:e1901071.CrossRefPubMedPubMedCentral Hu J, Albadawi H, Chong BW, Deipolyi AR, Sheth RA, Khademhosseini A, Oklu R. Advances in biomaterials and technologies for vascular embolization. Adv Mater. 2019;31:e1901071.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Torres D, Costa NV, Pisco J, Pinheiro LC, Oliveira AG, Bilhim T. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm embospheres. J Vasc Interv Radiol. 2019;30:638-44.CrossRefPubMed Torres D, Costa NV, Pisco J, Pinheiro LC, Oliveira AG, Bilhim T. Prostatic artery embolization for benign prostatic hyperplasia: prospective randomized trial of 100-300 μm versus 300-500 μm versus 100- to 300-μm + 300- to 500-μm embospheres. J Vasc Interv Radiol. 2019;30:638-44.CrossRefPubMed
18.
Zurück zum Zitat Pelage JP, Le Dref O, Beregi JP, Nonent M, Robert Y, Cosson M, Jacob D, Truc JB, Laurent A, Rymer R. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol. 2003;14:15-20.CrossRefPubMed Pelage JP, Le Dref O, Beregi JP, Nonent M, Robert Y, Cosson M, Jacob D, Truc JB, Laurent A, Rymer R. Limited uterine artery embolization with tris-acryl gelatin microspheres for uterine fibroids. J Vasc Interv Radiol. 2003;14:15-20.CrossRefPubMed
19.
Zurück zum Zitat Han K, Kim SY, Kim HJ, Kwon JH, Kim GM, Lee J, Won JY, Shin HJ, Yoon EJ, Kim MD. Nonspherical Polyvinyl Alcohol Particles versus Tris-Acryl Microspheres: Randomized Controlled Trial Comparing Pain after Uterine Artery Embolization for Symptomatic Fibroids. Radiology. 2021;298:458-65.CrossRefPubMed Han K, Kim SY, Kim HJ, Kwon JH, Kim GM, Lee J, Won JY, Shin HJ, Yoon EJ, Kim MD. Nonspherical Polyvinyl Alcohol Particles versus Tris-Acryl Microspheres: Randomized Controlled Trial Comparing Pain after Uterine Artery Embolization for Symptomatic Fibroids. Radiology. 2021;298:458-65.CrossRefPubMed
20.
Zurück zum Zitat Sutter O, Soyer P, Shotar E, Dautry R, Guerrache Y, Placé V, Opréa R, Ricbourg A, Le Dref O, Boudiaf M, Sirol M, Dohan A. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization. Eur Radiol. 2016;26:3558-70.CrossRefPubMed Sutter O, Soyer P, Shotar E, Dautry R, Guerrache Y, Placé V, Opréa R, Ricbourg A, Le Dref O, Boudiaf M, Sirol M, Dohan A. Diffusion-weighted MR imaging of uterine leiomyomas following uterine artery embolization. Eur Radiol. 2016;26:3558-70.CrossRefPubMed
21.
Zurück zum Zitat Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol. 2000;21:255-61.PubMedPubMedCentral Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol. 2000;21:255-61.PubMedPubMedCentral
22.
Zurück zum Zitat Tomashefski JF Jr, Cohen AM, Doershuk CF. Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis. Hum Pathol. 1988;19:555-61.CrossRefPubMed Tomashefski JF Jr, Cohen AM, Doershuk CF. Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis. Hum Pathol. 1988;19:555-61.CrossRefPubMed
23.
Zurück zum Zitat Davidson GS, Terbrugge KG. Histologic long-term follow-up after embolization with polyvinyl alcohol particles. AJNR Am J Neuroradiol. 1995;16(4 Suppl):843-6.PubMedPubMedCentral Davidson GS, Terbrugge KG. Histologic long-term follow-up after embolization with polyvinyl alcohol particles. AJNR Am J Neuroradiol. 1995;16(4 Suppl):843-6.PubMedPubMedCentral
24.
Zurück zum Zitat Laurent A, Wassef M, Namur J, Martal J, Labarre D, Pelage JP. Recanalization and particle exclusion after embolization of uterine arteries in sheep: a long-term study. Fertil Steril. 2009;91:884-92.CrossRefPubMed Laurent A, Wassef M, Namur J, Martal J, Labarre D, Pelage JP. Recanalization and particle exclusion after embolization of uterine arteries in sheep: a long-term study. Fertil Steril. 2009;91:884-92.CrossRefPubMed
25.
Zurück zum Zitat Lee KS, Bae WK, Doh JW, Bae HG, Yun IG. Origin of chronic subdural haematoma and relation to traumatic subdural lesions. Brain Inj. 1998;12:901-10.CrossRefPubMed Lee KS, Bae WK, Doh JW, Bae HG, Yun IG. Origin of chronic subdural haematoma and relation to traumatic subdural lesions. Brain Inj. 1998;12:901-10.CrossRefPubMed
26.
Zurück zum Zitat Markwalder TM, Reulen HJ. Influence of neomembranous organisation, cortical expansion and subdural pressure on the post-operative course of chronic subdural haematoma—an analysis of 201 cases. Acta Neurochir (Wien). 1986;79:100-6.CrossRefPubMed Markwalder TM, Reulen HJ. Influence of neomembranous organisation, cortical expansion and subdural pressure on the post-operative course of chronic subdural haematoma—an analysis of 201 cases. Acta Neurochir (Wien). 1986;79:100-6.CrossRefPubMed
27.
Zurück zum Zitat Ishibashi A, Yokokura Y, Miyagi J. Clinical analysis of nineteen patients with traumatic subdural hygromas. Kurume Med J. 1994;41:81-5.CrossRefPubMed Ishibashi A, Yokokura Y, Miyagi J. Clinical analysis of nineteen patients with traumatic subdural hygromas. Kurume Med J. 1994;41:81-5.CrossRefPubMed
28.
Zurück zum Zitat Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017;14:108.CrossRefPubMedPubMedCentral Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation. 2017;14:108.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Tanaka T, Fujimoto S, Saito K, Kaimori M. [Histological study of operated cases of chronic subdural hematoma in adults: relationship between dura mater and outer membrane]. No Shinkei Geka. 1997;25:701-5.PubMed Tanaka T, Fujimoto S, Saito K, Kaimori M. [Histological study of operated cases of chronic subdural hematoma in adults: relationship between dura mater and outer membrane]. No Shinkei Geka. 1997;25:701-5.PubMed
30.
Zurück zum Zitat Takizawa K, Sorimachi T, Ishizaka H, Osada T, Srivatanakul K, Momose H, Matsumae M. Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma. J Neurosurg. 2016;124:1679-83.CrossRefPubMed Takizawa K, Sorimachi T, Ishizaka H, Osada T, Srivatanakul K, Momose H, Matsumae M. Enlargement of the middle meningeal artery on MR angiography in chronic subdural hematoma. J Neurosurg. 2016;124:1679-83.CrossRefPubMed
Metadaten
Titel
Long-Term Middle Meningeal Artery Caliber Reduction Following Trisacryl Gelatine Microsphere Embolization for the Treatment of Chronic Subdural Hematoma
verfasst von
Eimad Shotar
Eric Barberis
Lydia Chougar
Sacha Bensoussan
Damien Parat
Haroun Ghannouchi
Kevin Premat
Stephanie Lenck
Vincent Degos
Stéphane Lehericy
Nader-Antoine Sourour
Bertrand Mathon
Frédéric Clarençon
Publikationsdatum
07.07.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 1/2023
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-022-01189-4

Weitere Artikel der Ausgabe 1/2023

Clinical Neuroradiology 1/2023 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.